Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class I · High risk Terminated Initiated Jan 9, 2016 (11 years ago)

Plant Vigra

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Marketed Without An Approved NDA/ANDA

Cause type: Unapproved drug

The product was marketed without an approved NDA/ANDA, or does not meet the OTC monograph it claims to follow. Nothing about the product - dose, purity, safety - has been reviewed by FDA, so the claims on the box are unverified. All unapproved drug recalls.

What was recalled

Plant Vigra, packaged in BIG BOX / (18 cans / 6 capsules per can / 108 capsules), Distributed by: R Thomas Marketing, LLC, Bronx, NY 10467

Recalling firm
R Thomas Marketing, LLC
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0899-2016 · FDA notice

Treat this as urgent. Class I means FDA judged there is a reasonable probability of serious harm. Find the lot number on your package; if it matches the recalled lots, do not take another dose before you have spoken to your pharmacist or prescriber - today, not next week. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by R Thomas Marketing, LLC

All 2016 recalls
Class I · High risk

Zhen Gong Fu

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0907-2016
Class I · High risk

Super Hard

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0906-2016
Class I · High risk

Samurai-X

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0905-2016
Class I · High risk

Tiger King

Marketed Without An Approved NDA/ANDA

Terminated Unapproved drug R Thomas Marketing, LLC D-0904-2016

Other unapproved drug recalls from 2016

All unapproved drug recalls
Class I · High risk

Domperidone capsules 10 mg

Marketed without an approved NDA/ANDA for which safety and efficacy has not been established.

Terminated Unapproved drug Jeffreys Drug Store D-0494-2017
Class II · Moderate risk

Zinc Acetate

Does not meet monograph: product exhibits lead levels in excess of the USP monograph limits.

Terminated Unapproved drug Spectrum Laboratory Products, Inc. D-1456-2016
Class II · Moderate risk

Oxygen Nasal Wash

Marketed Without An Approved NDA/ANDA: product is an unapproved drug due to nasal decongestant claims as well as not complying with the nasal decongestant final monograph.

Terminated Unapproved drug Let's Talk Health, Inc. D-1452-2016
Class II · Moderate risk

Fuqingsong Relief Cream

Marketed Without An Approved NDA/ANDA: Products marked as dietary supplements have labeling that bears drug/disease claims, making them unapproved drugs.

Terminated Unapproved drug Murray International Trading Co., Inc. D-1358-2016